Want to join the conversation?
$AMGN files an application with the FDA seeking clearance for a single once a month 420 mg injection of its cholesterol fighter Repatha (evolocumab), which is currently available in a single-use 140 mg/mL prefilled autoinjector which requires three subcu injection of 420 mg. The FDA cleared Repatha, a PCSK9 inhibitor, on Aug. 27, for lowering LDL-C
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.